Skip to main content
Caplight Logo









MiRus

MiRus

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://www.mirusmed.com/

Last Round

Corporate Funding

May 15, 2026

Est. Valuation

$4.44B

Total Funding Raised

$1.57B

Company Overview

MiRus is a medical technology company that develops and commercializes proprietary biomaterials, implants, and procedural solutions for the treatment of spinal, orthopedic, and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical devicestranscatheter aortic valve replacementTAVRspine implantsbiocompatible materialssurgical implantsmedtechMoRe alloysurgical planningstructural heartorthopedic hardwareclinical decision supportsurgical navigation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiRus Comparables

Compare MiRus with similar companies based on industry and business-model similarity.

MiRus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Meril Life Sciences
83%
Anteris Technologies Global Corp
83%
Edwards Lifesciences
81%

MiRus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 15, 2026
Series DJul 27, 2021

Key People

Founding team and executive leadership

Jay Yadav

Founder And CEO

Founding Team

Noah M. Roth

COO at MiRus, LLC

Executive Team

MiRus Investors

Notable investors and investment history

MiRus investors
InvestorRounds
Mammoth ScientificSeries C, Series B, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Pivotal trial for TAVR system underway, targeting FDA/EMA submissions.

  • Jul 27, 2021

    $65M round led by Mammoth Scientific.

MiRus Filings

Explore SEC and related filing metadata, where available.

MiRus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MiRus's valuation, stock price, and market status.

Is MiRus a public or private company?

MiRus is a private company.

What is the current stock price of MiRus?

MiRus is a private company with no public stock price. No recent secondary market data is available.

How much is MiRus worth (valuation)?

MiRus's valuation is estimated at $355.0M based on funding round data.

Can I buy MiRus stock?

MiRus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MiRus's last funding round?

MiRus's most recent funding round was Series D on July 27, 2021.

Who are the main investors in MiRus?

Key investors in MiRus include Mammoth Scientific.

Will MiRus IPO soon?

No public IPO plans have been announced for MiRus.

How can I track MiRus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MiRus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range100
Year Founded2016
Last FundingMay 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?